| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $4.2M | -50.2% |
| SG&A Expense | $9.1M | -2.2% |
| Operating Income | -$13.3M | +31.0% |
| Pre-tax Income | -$12.7M | +34.8% |
| Income Tax | -$502 | +99.5% |
| Net Income | -$12.7M | +34.5% |
| EPS (Basic) | -$0.51 | +51.0% |
| EPS (Diluted) | -$0.51 | +51.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.0M | -34.0% |
| Current Assets | $4.8M | -26.0% |
| Total Assets | $5.7M | -23.3% |
| Current Liabilities | $1.8M | -34.2% |
| Total Liabilities | $2.5M | -38.1% |
| Stockholders' Equity | $3.3M | -6.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.2M | +6.4% |
| Capital Expenditures | $65K | +0.0% |
| Investing Cash Flow | -$34K | +0.0% |
| Financing Cash Flow | $9.1M | -33.1% |
| Free Cash Flow | -$11.3M | +6.4% |